title: Why is Rheumatoid Arthritis Mortality Still High Despite the Advent of New Therapies? Comment on the Article by Widdifield et al.
authors.affiliation: Hospital Universitario Marqués de Valdecilla, and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: González-Gay
authors.affiliation: School of Medicine, University of Cantabria, IDIVAL, and CIBER Epidemiologíay Salud Pública (CIBERESP), Santander, Spain.
authors.forename: Javier
authors.initials: J
authors.lastname: Llorca
authors.affiliation: Hospital Lucus Augusti Lugo, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: González-Juanatey
authors.affiliation: Spanish Society of Rheumatology, Madrid, Spain.
authors.forename: María A
authors.initials: MA
authors.lastname: Martín-Martínez
authors.affiliation: Hospital Universitario de la Princesa, IIS-IPrincesa, Madrid, Spain.
authors.forename: Santos
authors.initials: S
authors.lastname: Castañeda
mesh_terms: D001172:Arthritis, Rheumatoid; D006801:Humans